PUBLISHED DATE : Jan 2023 | Pages : 221
Fill out your details & get your free sample
The Global Specialty Enzymes Market Size, Share, & Trends Analysis Report By
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022–2027
221 Pages
117 Tables
89 Charts
5 Regions
20 Countries
20 Companies
4 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (2027) | USD 4.56 Billion |
| Market Size (2021) | USD 2.96 Billion |
| CAGR (2021-2027) | 7.46% |
| Base Year | 2021 |
| Forecast Year | 2022-2027 |
| Market Segments | Type, End Use, Source, and Geography |
| Geographic Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
| KEY VENDORS | BASF SE, DSM, DuPont, F. Hoffmann-La Roche Ltd, and Novozymes |
The global specialty enzymes market size crossed USD 2.96 billion in 2021 and is expected to reach USD 4.56 billion by 2027, growing at a CAGR of 7.46% from 2021-2027. Factors such as the rapidly increasing global population, increasing research & development, spreading new infectious diseases, increasing biofuel usage, and growing agriculture industry led to increased demand for specialty enzymes in the global market. The major drivers of the specialty enzymes market include the increasing health consciousness and intense penetration of the pharmaceutical, diagnostics, and biotechnology industries.
Specialty enzymes are used in various industries for various purposes. In the pharmaceutical industry, these are used for manufacturing drugs for DNA/RNA treatment, cancer, heart-related disease, and other treatments. The demand is increasing due to increasing awareness and changing government policies. With the growing specialty enzymes markets, companies must increase the supply of raw materials to produce enzymes in bulk quantities. In the pharmaceutical industry, companies have started using biobased drugs to improve product quality. Companies are adopting sustainable standards in their manufacturing processes. The specialty enzymes market has helped to reduce the by-products in the production process. Companies are getting good financial returns by using specialty enzymes in the production processes. Thus, the global demand for specialty enzymes is increasing.
The US contributed more than half of the overall demand in North America. Globally, the demand for specialty enzymes is very high in the US, and North America dominates the global specialty enzymes market. The US has the world’s top 10 pharmaceutical companies’ head offices. Thus, the demand for specialty enzymes in North America's pharmaceutical industry is increasing with the growing pharmaceutical industry.
Increased Use in Diagnostics Sector
The diagnostics industry includes two categories such as pathology and radiology. Pathology is used for testing all types of illness, whereas radiology is used for testing images related to diagnoses such as x-rays, CT scans, and others. For the research & development of vaccines for various infectious diseases, enzymes are used. Enzymes are used in testing infectious diseases such as coronaviruses and influenza and are also used in nucleic acid detection. The enzymes are used in the diagnostics and analysis of biological abnormalities.
The diagnostics segment plays a crucial role in the healthcare sector. After the Covid-19 pandemic, the demand for proper diagnostic equipment and processes in the diagnostics sector is growing rapidly. In the testing of coronaviruses and other infectious diseases, enzymes are used. For immediate recovery from coronavirus diseases, antibiotics are used, which are produced from enzymes. Thus, the specialty enzymes market in the diagnostic sector is increasing globally.
Increasing Demand from Pharmaceutical Industry
The global revenue of the pharmaceutical industry is increasing due to the global demand for pharmaceutical products. The factors driving the demand for pharmaceutical products include changing clinical practices, aging-related issues, and rising chronic diseases. After the Covid-19 pandemic, the demand for pharmaceutical products used to improve quality of life and preventive approach. The global market of pharmaceutical drugs is increasing due to the lowering the regulatory barrier for new drugs in the US.
The health consciousness of people has increased after the Covid-19 pandemic. People prefer bio-based pharmaceutical products. Thus, the demand for bio-based substances used in manufacturing antibiotics is rising. Specialty enzymes are used in the pharmaceutical industry to increase the reaction rate and produce the desired molecules, contributing to the specialty enzymes market growth.
Technical Barriers Affecting Specialty Enzymes Market
Biocatalysis is a process that accelerates the chemical process by using biomolecules. It includes mild reaction and high selectivity conditions. Therefore, specialty enzymes play an essential role in the chemical industry and are gaining relevance in industrial applications. But, there is difficulty in finding the accurate protein structure of specialty enzymes. The process is time-consuming and requires more catalysts to fulfilling the need of the chemical reaction process. For the manufacturing process of these enzymes, specific conditions such as new concentration, new substrate, and other conditions are required which are not found readily in nature. These unresolved challenges make specialty enzymes unpredictive. Thus, more research & development is necessary for making enzymes in bulk amounts, creating a barrier to the specialty enzymes market growth.
INSIGHTS BY END-USE
In the pharmaceutical industry, specialty enzymes are very useful and good for treating various diseases. As there is increasing demand for pharmaceutical products, the enzyme has become essential to meet the demand for sustainable and safe industry processes. The specialty enzymes are primarily used in the pharmaceutical and biotechnology industry for research & development and diagnostics. The global specialty enzymes market in the pharmaceutical industry was valued at USD 976.56 million in 2021. The demand for specialty enzymes in North America and APAC is very high due to the increasing pharmaceutical and biotechnology industry.
In the biotechnology industry, specialty enzymes are used to increase biochemical reaction rates. Lipases are used in dietary drugs and it is used to increase the metabolism rate. Polymerases & nucleases are used in DNA amplification. In DNA amplification, the increase in the number of the gene causes an increase in proteins and RNA. Thus, it may increase the cancer cells or lower the anticancer cells. Hence, the polymerases & nucleases-based enzymes demand is growing in the global specialty enzymes market.
INSIGHTS BY TYPE
Carbohydrases have dominated the global specialty enzymes market and is expected to reach USD 1.9 billion by 2027. Carbohydrases are mainly used in the pharmaceutical industry as specialty enzymes. Most of these enzymes used in the pharmaceutical industry are produced from microorganisms, animals, and plants. Carbohydrases are further classified into glucosidase, pectinases, alpha, beta amylases, cellulases, mannanases, galacto, and pullulanase. These are the cost-effective processes in industrial applications; thus, a cheap technique is required to obstruct.
The global proteases-based specialty enzymes market surpassed USD813 million in 2021. The proteases are used in the biotechnology, pharmaceutical, and diagnostics industries—the high use of proteases in the pharmaceutical industry for prognostic and diagnostic biomarkers. Based on the catalysis mechanism, the proteases are classified into additional classes, such as glutamic, aspartic, metalloproteases, threonine, cysteine, and serine proteases which activate the water molecule and attack the proteins.
INSIGHTS BY SOURCE
Globally, microorganisms-based enzymes contributed 77.47%, followed by animal and plant-based enzymes in 2021 in the global specialty enzymes market. The demand for specialty enzymes is very high in North America, followed by Europe and APAC. Microorganisms and plant-based enzymes are easily found in the environment. Animal-based enzymes have fewer resources, and it isn't easy to produce in bulk quantities. Thus, companies are focusing on producing enzymes from microorganisms and plants.
The global plants-based specialty enzymes market was valued at USD 297.07 million in 2021. These are used in the agriculture industry to reduce insects from crops. The few plant-based enzymes are phosphatase, esterase, glucanase, chitinase, and others. These enzymes play a crucial role in the production of nutrition. Further, plant-based enzymes are being used to manufacture drugs in the pharmaceutical industry to improve the digestive system.
The global specialty enzymes market is diverse, with many established and potential growth markets. North America is the leading market because of rapidly developing infrastructure and readily increasing population, increasing demand for various pharmaceutical, biotechnology, and diagnostics industries. The specialty enzymes market in North America was valued at USD 1.2 billion in 2021.
Europe is the second-largest market for specialty enzymes. The growth is supported by the increasing demand for healthy pharmaceutical products, which is attributed to the rising health consciousness. Germany, France, Italy, Spain, the UK, Russia, and others led the region. In European countries, various companies are producing specialty enzymes that contribute to the global specialty enzymes market, such as BASF SE (Germany), Johnson Matthey (UK), Biocatalysts (UK), BBI Solutions (UK), and others. Furthermore, the demand is expected to grow significantly as the APAC region population has grown tremendously in recent years. China, Japan, India, and South Korea led the region. The population of APAC countries is increasing rapidly; thus, demand for pharmaceutical and diagnostics specialty enzymes is increasing. China, India, and Japan are the major pharmaceutical industry players in the APAC region.
The major companies in the specialty enzymes market are following the merger and acquisition strategy. This gives companies a competitive advantage that boosts their market share of the company. The key companies have undertaken various strategies to grow in the market. The growth in sustainable processes and initiatives has challenged all companies globally. Investments in R&D, technological advancement, and environmental and economic challenges drive the demand for innovative and sustainable specialty enzyme products.
Some major players in the global specialty enzymes market include Roche (Switzerland), BASF SE (Germany), DuPont (US), Novozymes (Denmark), and DSM (Netherlands). These players have adopted strategies like acquisitions, expansion, joint ventures, new product development, and others to increase their revenues in the industry. Other prominent companies such as Chr. Hansen Holding A/S (Denmark), Codexis (US), BBI Solutions (UK), and others have invested significant capital in R&D to develop specialty enzymes-based products that will appeal to customers. Therefore, these other prominent companies are giving tough competition to major companies.
Frequently Asked Questions
What was the global specialty enzymes market size in 2021?
The global specialty enzymes market size surpassed USD 2.96 billion in 2021 and is expected to reach USD 4.56 billion by 2027.
What is the growth rate of the global specialty enzymes market?
The global specialty enzymes market share is growing at a CAGR of 7.46% from 2021-2027.
What are the key trends in the Specialty Enzymes Market in the world?
The increasing demand from the pharmaceutical industry, adopting sustainability standards to improve profitability and productivity, and growing demand from emerging economies are key trends in the global specialty enzymes market.
Which are the key companies in the global specialty enzymes market?
The key global specialty enzymes market companies are BASF SE, DSM, DuPont, F. Hoffmann-La Roche Ltd, and Novozymes.
Which end-use segment is estimated to lead the Global Specialty Enzymes Market?
The pharmaceutical industry is estimated to dominate the global specialty enzymes market by end-use and will reach USD 1.4 billion by 2027. Due to the growth in the global population, the demand for pharmaceutical products is increasing. Due to people becoming more health conscious, pharmaceutical companies focus on increasing the bio-based drug content in drug formulations.
The specialty enzymes market is expected to grow at a CAGR of approximately 7.46% from 2021 to 2027.
The following factors are likely to contribute to the growth of the specialty enzymes market during the forecast period:
Base Year: 2021
Forecast Year: 2022-2027
The report considers the present scenario of the specialty enzymes market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the industry.
Key Vendors
Other Prominent Vendors
Segmentation by Type
Segmentation by End Use
Segmentation by Source
Segmentation by Geography
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 PREMIUM INSIGHTS
6.1 INTRODUCTION
6.2 MARKET SYNOPSIS
6.2.1 DRIVERS
6.2.2 OPPORTUNITY
6.2.3 CHALLENGES
6.3 SEGMENT REVIEW
6.3.1 END-USE
6.3.2 TYPE
6.3.3 SOURCE
6.3.4 GEOGRAPHY
6.4 COMPANIES & STRATEGIES
7 MARKET AT A GLANCE
8 INTRODUCTION
8.1 OVERVIEW
8.2 VALUE CHAIN ANALYSIS
8.2.1 RAW MATERIALS
8.2.2 SPECIALTY ENZYME MANUFACTURERS
8.2.3 DISTRIBUTORS
8.2.4 APPLICATIONS
8.3 MACROECONOMIC FACTORS
8.3.1 PHARMACEUTICAL INDUSTRY
9 MARKET OPPORTUNITIES & TRENDS
9.1 DEMAND FROM PHARMACEUTICAL INDUSTRY
9.2 ADOPTION OF SUSTAINABILITY STANDARDS TO IMPROVE PROFITABILITY & PRODUCTIVITY
9.3 DEMAND FROM EMERGING ECONOMIES
10 MARKET GROWTH ENABLERS
10.1 DEMAND FOR BIO-SOURCED PRODUCTS
10.2 INCREASED USE IN DIAGNOSTICS SECTOR
10.3 INCREASED R&D & PRODUCT INNOVATION IN DEVELOPED COUNTRIES
11 MARKET RESTRAINTS
11.1 LACK OF AWARENESS OF BIO-BASED PRODUCTS
11.2 EXISTENCE OF VARIOUS TECHNICAL BARRIERS
11.3 HIGH MANUFACTURING COST
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 BY TYPE
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 CARBOHYDRASES
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET BY GEOGRAPHY
13.4 PROTEASES
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
13.5 LIPASES
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.5.3 MARKET BY GEOGRAPHY
13.6 POLYMERASES & NUCLEASES
13.6.1 MARKET OVERVIEW
13.6.2 MARKET SIZE & FORECAST
13.6.3 MARKET BY GEOGRAPHY
13.7 OTHER
13.7.1 MARKET OVERVIEW
13.7.2 MARKET SIZE & FORECAST
13.7.3 MARKET BY GEOGRAPHY
14 BY END-USE
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 PHARMACEUTICAL
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 BIOTECHNOLOGY
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
14.5 DIAGNOSTICS
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 MARKET BY GEOGRAPHY
14.6 OTHER END-USE
14.6.1 MARKET OVERVIEW
14.6.2 MARKET SIZE & FORECAST
14.6.3 MARKET BY GEOGRAPHY
15 BY SOURCE
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 MICROORGANISM
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 MARKET BY GEOGRAPHY
15.4 PLANT
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 MARKET BY GEOGRAPHY
15.5 ANIMAL
15.5.1 MARKET OVERVIEW
15.5.2 MARKET SIZE & FORECAST
15.5.3 MARKET BY GEOGRAPHY
16 GEOGRAPHY
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 GEOGRAPHIC OVERVIEW
17 NORTH AMERICA
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.3 TYPE
17.3.1 MARKET SIZE & FORECAST
17.4 END-USE
17.4.1 MARKET SIZE & FORECAST
17.5 SOURCE
17.5.1 MARKET SIZE & FORECAST
17.6 KEY COUNTRIES
17.7 US
17.7.1 MARKET SIZE & FORECAST
17.8 CANADA
17.8.1 MARKET SIZE & FORECAST
18 EUROPE
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 TYPE
18.3.1 MARKET SIZE & FORECAST
18.4 END-USE
18.4.1 MARKET SIZE & FORECAST
18.5 SOURCE
18.5.1 MARKET SIZE & FORECAST
18.6 KEY COUNTRIES
18.7 GERMANY
18.7.1 MARKET SIZE & FORECAST
18.8 FRANCE
18.8.1 MARKET SIZE & FORECAST
18.9 ITALY
18.9.1 MARKET SIZE & FORECAST
18.10 SPAIN
18.10.1 MARKET SIZE & FORECAST
18.11 UK
18.11.1 MARKET SIZE & FORECAST
18.12 RUSSIA
18.12.1 MARKET SIZE & FORECAST
18.13 REST OF EUROPE
18.13.1 MARKET SIZE & FORECAST
19 APAC
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 TYPE
19.3.1 MARKET SIZE & FORECAST
19.4 END-USE
19.4.1 MARKET SIZE & FORECAST
19.5 SOURCE
19.5.1 MARKET SIZE & FORECAST
19.6 KEY COUNTRIES
19.7 CHINA
19.7.1 MARKET SIZE & FORECAST
19.8 JAPAN
19.8.1 MARKET SIZE & FORECAST
19.9 INDIA
19.9.1 MARKET SIZE & FORECAST
19.10 SOUTH KOREA
19.10.1 MARKET SIZE & FORECAST
19.11 REST OF APAC
19.11.1 MARKET SIZE & FORECAST
20 MIDDLE EAST & AFRICA
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 TYPE
20.3.1 MARKET SIZE & FORECAST
20.4 END-USE
20.4.1 MARKET SIZE & FORECAST
20.5 SOURCE
20.5.1 MARKET SIZE & FORECAST
20.6 KEY COUNTRIES
20.7 SAUDI ARABIA
20.7.1 MARKET SIZE & FORECAST
20.8 SOUTH AFRICA
20.8.1 MARKET SIZE & FORECAST
20.9 REST OF MIDDLE EAST & AFRICA
20.9.1 MARKET SIZE & FORECAST
21 LATIN AMERICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 TYPE
21.3.1 MARKET SIZE & FORECAST
21.4 END-USE
21.4.1 MARKET SIZE & FORECAST
21.5 SOURCE
21.5.1 MARKET SIZE & FORECAST
21.6 KEY COUNTRIES
21.7 BRAZIL
21.7.1 MARKET SIZE & FORECAST
21.8 MEXICO
21.8.1 MARKET SIZE & FORECAST
21.9 REST OF LATIN AMERICA
21.9.1 MARKET SIZE & FORECAST
22 COMPETITIVE LANDSCAPE
22.1 COMPETITION OVERVIEW
22.2 RECENT DEVELOPMENTS
23 KEY COMPANY PROFILES
23.1 BASF SE
23.1.1 BUSINESS OVERVIEW
23.1.2 FINANCIAL OVERVIEW
23.1.3 PRODUCT OFFERINGS
23.1.4 KEY STRATEGIES
23.1.5 KEY STRENGTHS
23.1.6 KEY OPPORTUNITIES
23.2 DSM
23.2.1 BUSINESS OVERVIEW
23.2.2 FINANCIAL OVERVIEW
23.2.3 PRODUCT OFFERINGS
23.2.4 KEY STRATEGIES
23.2.5 KEY STRENGTHS
23.2.6 KEY OPPORTUNITIES
23.3 DUPONT
23.3.1 BUSINESS OVERVIEW
23.3.2 FINANCIAL OVERVIEW
23.3.3 PRODUCT OFFERINGS
23.3.4 KEY STRATEGIES
23.3.5 KEY STRENGTHS
23.3.6 KEY OPPORTUNITIES
23.4 F. HOFFMANN-LA ROCHE LTD
23.4.1 BUSINESS OVERVIEW
23.4.2 FINANCIAL OVERVIEW
23.4.3 PRODUCT OFFERINGS
23.4.4 KEY STRATEGIES
23.4.5 KEY STRENGTHS
23.4.6 KEY OPPORTUNITIES
23.5 NOVOZYMES
23.5.1 BUSINESS OVERVIEW
23.5.2 FINANCIAL OVERVIEW
23.5.3 PRODUCT OFFERINGS
23.5.4 KEY STRATEGIES
23.5.5 KEY STRENGTHS
23.5.6 KEY OPPORTUNITIES
24 OTHER PROMINENT VENDORS
24.1 AMANO ENZYME INC.
24.1.1 COMPANY OVERVIEW
24.1.2 BUSINESS OVERVIEW
24.1.3 PRODUCT OFFERINGS
24.2 AMYRA BIOTECH AG
24.2.1 COMPANY OVERVIEW
24.2.2 PRODUCT OFFERINGS
24.3 ANTOZYME BIOTECH PVT LTD
24.3.1 COMPANY OVERVIEW
24.3.2 BUSINESS OVERVIEW
24.3.3 PRODUCT OFFERINGS
24.4 AUMGENE BIOSCIENCES
24.4.1 COMPANY OVERVIEW
24.4.2 BUSINESS OVERVIEW
24.4.3 PRODUCT OFFERINGS
24.5 AUMENZYMES
24.5.1 COMPANY OVERVIEW
24.5.2 PRODUCT OFFERINGS
24.6 BBI SOLUTIONS
24.6.1 COMPANY OVERVIEW
24.6.2 BUSINESS OVERVIEW
24.6.3 PRODUCT OFFERINGS
24.7 BIOCATALYSTS
24.7.1 COMPANY OVERVIEW
24.7.2 BUSINESS OVERVIEW
24.7.3 PRODUCT OFFERINGS
24.8 CODEXIS
24.8.1 COMPANY OVERVIEW
24.8.2 BUSINESS OVERVIEW
24.8.3 PRODUCT OFFERINGS
24.9 CHR. HANSEN HOLDING A/S
24.9.1 COMPANY OVERVIEW
24.9.2 BUSINESS OVERVIEW
24.9.3 PRODUCT OFFERINGS
24.10 DYADIC INTERNATIONAL INC.
24.10.1 COMPANY OVERVIEW
24.10.2 BUSINESS OVERVIEW
24.10.3 PRODUCT OFFERINGS
24.11 IOSYNTH
24.11.1 COMPANY OVERVIEW
24.11.2 BUSINESS OVERVIEW
24.11.3 PRODUCT OFFERINGS
24.12 MERCK KGAA
24.12.1 COMPANY OVERVIEW
24.12.2 BUSINESS OVERVIEW
24.12.3 PRODUCT OFFERINGS
24.13 NATURE BIOSCIENCE PVT. LTD.
24.13.1 COMPANY OVERVIEW
24.13.2 BUSINESS OVERVIEW
24.13.3 PRODUCT OFFERINGS
24.14 SPECIALTY ENZYMES & PROBIOTICS
24.14.1 COMPANY OVERVIEW
24.14.2 BUSINESS OVERVIEW
24.14.3 PRODUCT OFFERINGS
24.15 ZYMTRONIX, INC.
24.15.1 COMPANY OVERVIEW
24.15.2 PRODUCT OFFERINGS
25 REPORT SUMMARY
25.1 KEY TAKEAWAYS
25.2 STRATEGIC RECOMMENDATIONS
26 QUANTITATIVE SUMMARY
26.1 TYPE
26.1.1 CARBOHYDRASES
26.1.2 PROTEASES
26.1.3 LIPASES
26.1.4 POLYMERASES & NUCLEASES
26.1.5 OTHER
26.2 END-USE
26.2.1 PHARMACEUTICAL
26.2.2 BIOTECHNOLOGY
26.2.3 DIAGNOSTICS
26.2.4 OTHER END-USE
26.3 SOURCE
26.3.1 MICROORGANISM
26.3.2 PLANT
26.3.3 ANIMAL
26.4 GEOGRAPHY
26.5 NORTH AMERICA
26.5.1 TYPE
26.5.2 END-USE
26.5.3 SOURCE
26.6 EUROPE
26.6.1 TYPE
26.6.2 END-USE
26.6.3 SOURCE
26.7 APAC
26.7.1 TYPE
26.7.2 END-USE
26.7.3 SOURCE
26.8 MIDDLE EAST & AFRICA
26.8.1 TYPE
26.8.2 END-USE
26.8.3 SOURCE
26.9 LATIN AMERICA
26.9.1 TYPE
26.9.2 END-USE
26.9.3 SOURCE
27 APPENDIX
27.1 ABBREVIATIONS
EXHIBIT 1 SEGMENTATION OF GLOBAL SPECIALTY ENZYMES MARKET
EXHIBIT 2 GLOBAL SPECIALTY ENZYMES MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 GLOBAL SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 4 SHARE OF GLOBAL SPECIALTY ENZYMES MARKET BY GEOGRAPHY IN 2021 (%)
EXHIBIT 5 VALUE CHAIN ANALYSIS OF GLOBAL SPECIALTY ENZYMES MARKET
EXHIBIT 6 GEOGRAPHICAL ANALYSIS - SALES OF NEW MEDICINES LAUNCHED (2015–2020)
EXHIBIT 7 PHARMACEUTICAL R&D EXPENDITURE: EUROPE & US ($ MILLION) (1990–2020)
EXHIBIT 8 IMPACT OF DEMAND FROM PHARMACEUTICAL INDUSTRY
EXHIBIT 9 GLOBAL NUMBER OF PHARMACEUTICAL DRUG USERS (MILLION)
EXHIBIT 10 IMPACT OF ADOPTION OF SUSTAINABILITY STANDARDS TO IMPROVE PROFITABILITY & PRODUCTIVITY
EXHIBIT 11 IMPACT OF DEMAND FROM EMERGING ECONOMIES
EXHIBIT 12 APAC PHARMACEUTICAL MARKET SIZE 2018 ($ BILLION)
EXHIBIT 13 IMPACT OF DEMAND FOR BIO-SOURCED PRODUCTS
EXHIBIT 14 IMPACT OF INCREASED USE IN DIAGNOSTICS SECTOR
EXHIBIT 15 % MORTALITY DUE TO CARDIOVASCULAR DISEASES, CANCER & DIABETES IN SELECT COUNTRIES (AGES BETWEEN 30 AND 70)
EXHIBIT 16 IMPACT OF INCREASED R&D & PRODUCT INNOVATION IN DEVELOPED COUNTRIES
EXHIBIT 17 IMPACT OF LACK OF AWARENESS OF BIO-BASED PRODUCTS
EXHIBIT 18 IMPACT OF EXISTENCE OF VARIOUS TECHNICAL BARRIERS
EXHIBIT 19 CONDITIONS REQUIRED FOR ENZYMOLOGY PROCESS
EXHIBIT 20 IMPACT OF HIGH MANUFACTURING COST
EXHIBIT 21 DESIGNED SPECIALTY ENZYME PRODUCTION FACILITY ANNUAL OPERATING COST (%)
EXHIBIT 22 GLOBAL SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 23 FIVE FORCES ANALYSIS 2021
EXHIBIT 24 INCREMENTAL GROWTH BY TYPE 2021 & 2027
EXHIBIT 25 GLOBAL CARBOHYDRASES SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 26 GLOBAL PROTEASES SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 27 GLOBAL LIPASES SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 28 GLOBAL POLYMERASES & NUCLEASES SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 29 GLOBAL OTHER SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 30 INCREMENTAL GROWTH BY END-USE 2021 & 2027
EXHIBIT 31 GLOBAL PHARMACEUTICAL SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 32 GLOBAL BIOTECHNOLOGY SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 33 GLOBAL DIAGNOSTICS SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 34 GLOBAL OTHER END-USE SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 35 INCREMENTAL GROWTH BY SOURCE 2021 & 2027
EXHIBIT 36 GLOBAL MICROORGANISM-BASED SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 37 GLOBAL PLANT-BASED SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 38 GLOBAL ANIMAL-BASED SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 39 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 40 NORTH AMERICA SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 41 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
EXHIBIT 42 US SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 43 CANADA SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 44 EUROPE SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 45 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
EXHIBIT 46 GERMANY SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 47 FRANCE SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 48 ITALY SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 49 SPAIN SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 50 UK SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 51 RUSSIA SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 52 REST OF EUROPE SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 53 APAC SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 54 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
EXHIBIT 55 CHINA SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 56 JAPAN SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 57 INDIA SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 58 SOUTH KOREA SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 59 REST OF APAC SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 60 MIDDLE EAST & AFRICA SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 61 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
EXHIBIT 62 SAUDI ARABIA SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 63 SOUTH AFRICA SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 64 REST OF MIDDLE EAST & AFRICA SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 65 LATIN AMERICA SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 66 INCREMENTAL GROWTH IN REST OF LATIN AMERICA 2021 & 2027
EXHIBIT 67 BRAZIL SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 68 MEXICO SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 69 REST OF LATIN AMERICA SPECIALTY ENZYMES MARKET 2021–2027 ($ MILLION)
EXHIBIT 70 FINANCIAL OVERVIEW ($ BILLION)
EXHIBIT 71 SEGMENTAL REVENUE: 2021 ($ BILLION)
EXHIBIT 72 FINANCIAL OVERVIEW ($ BILLION)
EXHIBIT 73 FINANCIAL OVERVIEW ($ BILLION)
EXHIBIT 74 SEGMENTAL REVENUE: 2021 ($ BILLION)
EXHIBIT 75 FINANCIAL OVERVIEW ($ BILLION)
EXHIBIT 76 SEGMENTAL REVENUE: 2021 ($ BILLION)
EXHIBIT 77 FINANCIAL OVERVIEW ($ BILLION)
EXHIBIT 78 AMANO ENZYME INC.: BUSINESS & FINANCIAL OVERVIEW
EXHIBIT 79 ANTOZYME BIOTECH PVT LTD: BUSINESS & FINANCIAL OVERVIEW
EXHIBIT 80 AUMGENE BIOSCIENCES: BUSINESS & FINANCIAL OVERVIEW
EXHIBIT 81 BBI SOLUTIONS: BUSINESS & FINANCIAL OVERVIEW
EXHIBIT 82 BIOCATALYSTS: BUSINESS & FINANCIAL OVERVIEW
EXHIBIT 83 CODEXIS: BUSINESS & FINANCIAL OVERVIEW
EXHIBIT 84 CHR. HANSEN HOLDING A/S: BUSINESS & FINANCIAL OVERVIEW
EXHIBIT 85 DYADIC INTERNATIONAL INC.: BUSINESS & FINANCIAL OVERVIEW
EXHIBIT 86 IOSYNTH: BUSINESS & FINANCIAL OVERVIEW
EXHIBIT 87 MERCK KGAA: BUSINESS & FINANCIAL OVERVIEW
EXHIBIT 88 NATURE BIOSCIENCE PVT. LTD.: BUSINESS & FINANCIAL OVERVIEW
EXHIBIT 89 SPECIALTY ENZYMES & PROBIOTICS: BUSINESS & FINANCIAL OVERVIEW
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015–2021
TABLE 3 OVERVIEW OF PHARMACEUTICAL INDUSTRY IN EUROPE ($ MILLION)
TABLE 4 DEVELOPMENT OF GLOBAL MEDICINES (UNITS)
TABLE 5 CARBOHYDRASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 6 CARBOHYDRASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 7 PROTEASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 8 PROTEASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 9 LIPASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 10 LIPASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 11 POLYMERASES & NUCLEASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 12 POLYMERASES & NUCLEASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 13 OTHER SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 14 OTHER SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 15 PHARMACEUTICAL SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 16 PHARMACEUTICAL SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 17 BIOTECHNOLOGY SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 18 BIOTECHNOLOGY SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 19 DIAGNOSTICS SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 20 DIAGNOSTICS SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 21 OTHER END-USE SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 22 OTHER END-USE SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 23 MICROORGANISM-BASED SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 24 MICROORGANISM-BASED SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 25 PLANT-BASED SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 26 PLANT-BASED SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 27 ANIMAL-BASED SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 28 ANIMALS-BASED SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 29 NORTH AMERICA SPECIALTY ENZYMES MARKET BY TYPE 2021–2027 ($ MILLION)
TABLE 30 NORTH AMERICA SPECIALTY ENZYMES MARKET BY TYPE 2021–2027 (%)
TABLE 31 NORTH AMERICA SPECIALTY ENZYMES MARKET BY END-USE 2021–2027 ($ MILLION)
TABLE 32 NORTH AMERICA SPECIALTY ENZYMES MARKET BY END-USE 2021–2027 (%)
TABLE 33 NORTH AMERICA SPECIALTY ENZYMES MARKET BY SOURCE 2021–2027 ($ MILLION)
TABLE 34 NORTH AMERICA SPECIALTY ENZYMES MARKET BY SOURCE 2021–2027 (%)
TABLE 35 EUROPE SPECIALTY ENZYMES MARKET BY TYPE 2021–2027 ($ MILLION)
TABLE 36 EUROPE SPECIALTY ENZYMES MARKET BY TYPE 2021–2027 (%)
TABLE 37 EUROPE SPECIALTY ENZYMES MARKET BY END-USE 2021–2027 ($ MILLION)
TABLE 38 EUROPE SPECIALTY ENZYMES MARKET BY END-USE 2021–2027 (%)
TABLE 39 EUROPE SPECIALTY ENZYMES MARKET BY SOURCE 2021–2027 ($ MILLION)
TABLE 40 EUROPE SPECIALTY ENZYMES MARKET BY SOURCE 2021–2027 (%)
TABLE 41 APAC SPECIALTY ENZYMES MARKET BY TYPE 2021–2027 ($ MILLION)
TABLE 42 APAC SPECIALTY ENZYMES MARKET BY TYPE 2021–2027 (%)
TABLE 43 APAC SPECIALTY ENZYMES MARKET BY END-USE 2021–2027 ($ MILLION)
TABLE 44 APAC SPECIALTY ENZYMES MARKET BY END-USE 2021–2027 (%)
TABLE 45 APAC SPECIALTY ENZYMES MARKET BY SOURCE 2021–2027 ($ MILLION)
TABLE 46 APAC SPECIALTY ENZYMES MARKET BY SOURCE 2021–2027 (%)
TABLE 47 MIDDLE EAST & AFRICA SPECIALTY ENZYMES MARKET BY TYPE 2021–2027 ($ MILLION)
TABLE 48 MIDDLE EAST & AFRICA SPECIALTY ENZYMES MARKET BY TYPE 2021–2027 (%)
TABLE 49 MIDDLE EAST & AFRICA SPECIALTY ENZYMES MARKET BY END-USE 2021–2027 ($ MILLION)
TABLE 50 MIDDLE EAST & AFRICA SPECIALTY ENZYMES MARKET BY END-USE 2021–2027 (%)
TABLE 51 MIDDLE EAST & AFRICA SPECIALTY ENZYMES MARKET BY SOURCE 2021–2027 ($ MILLION)
TABLE 52 MIDDLE EAST & AFRICA SPECIALTY ENZYMES MARKET BY SOURCE 2021–2027 (%)
TABLE 53 LATIN AMERICA SPECIALTY ENZYMES MARKET BY TYPE 2021–2027 ($ MILLION)
TABLE 54 LATIN AMERICA SPECIALTY ENZYMES MARKET BY TYPE 2021–2027 (%)
TABLE 55 LATIN AMERICA SPECIALTY ENZYMES MARKET BY END-USE 2021–2027 ($ MILLION)
TABLE 56 LATIN AMERICA SPECIALTY ENZYMES MARKET BY END-USE 2021–2027 (%)
TABLE 57 LATIN AMERICA SPECIALTY ENZYMES MARKET BY SOURCE 2021–2027 ($ MILLION)
TABLE 58 LATIN AMERICA SPECIALTY ENZYMES MARKET BY SOURCE 2021–2027 (%)
TABLE 59 BASF SE: MAJOR PRODUCT OFFERINGS
TABLE 60 DSM: MAJOR PRODUCT OFFERINGS
TABLE 61 DUPONT: MAJOR PRODUCT OFFERINGS
TABLE 62 F. HOFFMANN-LA ROCHE LTD: MAJOR PRODUCT OFFERINGS
TABLE 63 NOVOZYMES: MAJOR PRODUCT OFFERINGS
TABLE 64 AMANO ENZYME INC.: MAJOR PRODUCT OFFERINGS
TABLE 65 AMAYRA BIOTECH AG: MAJOR PRODUCT OFFERINGS
TABLE 66 ANTOZYME BIOTECH PVT LTD: MAJOR PRODUCT OFFERINGS
TABLE 67 AUMGENE BIOSCIENCES: MAJOR PRODUCT OFFERINGS
TABLE 68 AUMENZYMES: MAJOR PRODUCT OFFERINGS
TABLE 69 BBI SOLUTIONS: MAJOR PRODUCT OFFERINGS
TABLE 70 BIOCATALYSTS: MAJOR PRODUCT OFFERINGS
TABLE 71 CODEXIS: MAJOR PRODUCT OFFERINGS
TABLE 72 C CHR. HANSEN HOLDING A/S: MAJOR PRODUCT OFFERINGS
TABLE 73 DYADIC INTERNATIONAL INC.: MAJOR PRODUCT OFFERINGS
TABLE 74 IOSYNTH: MAJOR PRODUCT OFFERINGS
TABLE 75 MERCK KGAA: MAJOR PRODUCT OFFERINGS
TABLE 76 NATURE BIOSCIENCE PVT. LTD.: MAJOR PRODUCT OFFERINGS
TABLE 77 SPECIALTY ENZYMES & PROBIOTICS: MAJOR PRODUCT OFFERINGS
TABLE 78 ZYMTRONIX, INC.: MAJOR PRODUCT OFFERINGS
TABLE 79 GLOBAL CARBOHYDRASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 80 GLOBAL CARBOHYDRASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 81 GLOBAL PROTEASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 82 GLOBAL PROTEASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 83 GLOBAL LIPASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 84 GLOBAL LIPASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 85 GLOBAL POLYMERASES & NUCLEASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 86 GLOBAL POLYMERASES & NUCLEASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 87 GLOBAL OTHER SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 88 GLOBAL OTHER SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 89 GLOBAL PHARMACEUTICAL SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 90 GLOBAL PHARMACEUTICAL SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 91 GLOBAL BIOTECHNOLOGY SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 92 GLOBAL BIOTECHNOLOGY SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 93 GLOBAL DIAGNOSTICS SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 94 GLOBAL DIAGNOSTICS SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 95 GLOBAL OTHER END-USE SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 96 GLOBAL OTHER END-USE SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 97 GLOBAL MICROORGANISM-BASED SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 98 GLOBAL MICROORGANISM-BASED SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 99 GLOBAL PLANT-BASED SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 100 GLOBAL PLANT-BASED SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 101 GLOBAL ANIMAL-BASED SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 102 GLOBAL ANIMAL-BASED SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 103 NORTH AMERICA SPECIALTY ENZYMES MARKET BY TYPE 2021–2027 ($ MILLION)
TABLE 104 NORTH AMERICA SPECIALTY ENZYMES MARKET BY END-USE 2021–2027 ($ MILLION)
TABLE 105 NORTH AMERICA SPECIALTY ENZYMES MARKET BY SOURCE 2021–2027 ($ MILLION)
TABLE 106 EUROPE SPECIALTY ENZYMES MARKET BY TYPE 2021–2027 ($ MILLION)
TABLE 107 EUROPE SPECIALTY ENZYMES MARKET BY END-USE 2021–2027 ($ MILLION)
TABLE 108 EUROPE SPECIALTY ENZYMES MARKET BY SOURCE 2021–2027 ($ MILLION)
TABLE 109 APAC SPECIALTY ENZYMES MARKET BY TYPE 2021–2027 ($ MILLION)
TABLE 110 APAC SPECIALTY ENZYMES MARKET BY END-USE 2021–2027 ($ MILLION)
TABLE 111 APAC SPECIALTY ENZYMES MARKET BY SOURCE 2021–2027 ($ MILLION)
TABLE 112 MIDDLE EAST & AFRICA SPECIALTY ENZYMES MARKET BY TYPE 2021–2027 ($ MILLION)
TABLE 113 MIDDLE EAST & AFRICA SPECIALTY ENZYMES MARKET BY END-USE 2021–2027 ($ MILLION)
TABLE 114 MIDDLE EAST & AFRICA SPECIALTY ENZYMES MARKET BY SOURCE 2021–2027 ($ MILLION)
TABLE 115 LATIN AMERICA SPECIALTY ENZYMES MARKET BY TYPE 2021–2027 ($ MILLION)
TABLE 116 LATIN AMERICA SPECIALTY ENZYMES MARKET BY END-USE 2021–2027 ($ MILLION)
TABLE 117 LATIN AMERICA SPECIALTY ENZYMES MARKET BY SOURCE 2021–2027 ($ MILLION)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
